Website: Our Research

clinical trial location

Clinical Trial Update: What We Will Learn from Side-Out 3

For 12 years, we have been working to personalize treatments through clinical trials for breast cancer patients – because no two are exactly alike. This work has been supported by the fundraising of hundreds of dedicated and passionate volleyball teams around the country through Side-Out’s Dig Pink® initiative. Most recently we have concluded the enrollment

Clinical Trial Update: What We Will Learn from Side-Out 3 Read More »

metastatic breast cancer research

The State of Research for Metastatic Breast Cancer

Approximately 2 percent of cancer research focuses on metastatic cancer of all different types. Research for metastatic breast cancer receives about 5 percent of that 2 percent. Since metastatic breast cancer affects 30 percent of all breast cancer patients, Metavivor has proposed that metastatic breast cancer research receive 30 percent of the breast cancer research

The State of Research for Metastatic Breast Cancer Read More »

Phrma Research & Hope Award

Side-Out Wins National 2015 PhRMA Research & Hope Award

Washington, D.C., September 10, 2015 — Northern Virginia-based non-profit, The Side-Out Foundation, was honored by the Pharmaceutical Research and Manufacturers of America (PhRMA Research) with the Community Champion Research & Hope Award at a celebration in Washington, D.C. on Wednesday evening, the foundation announced. The award recognizes Side-Out for its outstanding achievements in the fight

Side-Out Wins National 2015 PhRMA Research & Hope Award Read More »

Dr. Robert Invited to Serve on ASCO’s Cancer Research Committee

Dr. Nicholas Robert, one of The Side-Out Foundation’s scientific advisors, was recently invited to serve as a member of the Cancer Research Committee for the American Society of Clinical Oncology (ASCO), the world’s premier professional organization of oncologists. The organization includes approximately 30,000 members worldwide, clincial oncologists of multiple specialties and interests. Dr. Robert’s appointment

Dr. Robert Invited to Serve on ASCO’s Cancer Research Committee Read More »